PeptideDB

R 396

CAS No.: 129809-09-2

R 396 (Acleu-asp-gln-trp-phe-glynh2) is a linear hexapeptide and is also an NK-2 tachykinin receptor antagonist.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description R 396 (Acleu-asp-gln-trp-phe-glynh2) is a linear hexapeptide and is also an NK-2 tachykinin receptor antagonist.
Synonyms Acleu-asp-gln-trp-phe-glynh2, 速激肽拮抗剂多肽
molecular weight 805.88
Molecular formula C39H51N9O10
CAS 129809-09-2
Storage keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
References 1. Pluck G. Preliminary Validation of a Free-to-Use, Brief Assessment of Adult Intelligence for Research Purposes: The Matrix Matching Test. Psychol Rep. 2018 Jan 1:33294118762589. doi: 10.1177/0033294118762589. [Epub ahead of print] PubMed PMID: 29540106. 2. Giannouli E, Bock O, Zijlstra W. Cognitive functioning is more closely related to real-life mobility than to laboratory-based mobility parameters. Eur J Ageing. 2017 Jun 20;15(1):57-65. doi: 10.1007/s10433-017-0434-3. eCollection 2018 Mar. PubMed PMID: 29531515; PubMed Central PMCID: PMC5840094. 3. Kardeş S, Karagülle M, Durak İ, Avcı A, Karagülle MZ. Association of oxidative stress with clinical characteristics in patients with rheumatoid arthritis. Eur J Clin Invest. 2018 Jan;48(1). doi: 10.1111/eci.12858. Epub 2017 Dec 8. PubMed PMID: 29144558. 4. Anyfanti P, Triantafyllou A, Gkaliagkousi E, Koletsos N, Athanasopoulos G, Zabulis X, Galanopoulou V, Aslanidis S, Douma S. Retinal vessel morphology in rheumatoid arthritis: Association with systemic inflammation, subclinical atherosclerosis, and cardiovascular risk. Microcirculation. 2017 Nov;24(8). doi: 10.1111/micc.12417. PubMed PMID: 28926162.